Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02063828 · ClinicalTrials.gov registry record · NA
Reducing Lung Cancer-Related Anxiety (RELAX)
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT02063828 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 46 participants.
The verdict
NCT02063828, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare the effects of music and different levels of device-guided breathing on anxiety and shortness of breath in lung cancer survivors.
Interventions
- DEVICE Group A - Device guided breathing low dose
- DEVICE Group B - Device guided breathing high dose
- DEVICE Group C - Usual Breathing Control Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2015-07-30 |
| Est. Completion | 2019-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02063828
The ClinicalTrials.gov registry entry for NCT02063828 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Group A - Device guided breathing low dose is the first listed.
NCT02063828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02063828 about?
NCT02063828 is a clinical study titled "Reducing Lung Cancer-Related Anxiety (RELAX)". The purpose of this research study is to compare the effects of music and different levels of device-guided breathing on anxiety and shortness of breath in lung cancer survivors.
What is the current status of trial NCT02063828?
This trial is currently terminated. It is a NA study. The enrollment target is 46 participants. The study started on 2015-07-30. Estimated completion is 2019-12-23.
What interventions are being tested in trial NCT02063828?
The interventions under investigation include: Group A - Device guided breathing low dose (DEVICE), Group B - Device guided breathing high dose (DEVICE), Group C - Usual Breathing Control Group (DEVICE).
Who is sponsoring clinical trial NCT02063828?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.